Arkolith/Insider Trading/RPHM/Form 4

Leonard Braden Michael

10% OwnerReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed Sep 19, 2024
Net Buying
Open-Market Buys
$76K
Open-Market Sells
$0
Net Open-Market Flow
$76K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2024Buy(P)806$1.40$1K3.4M
Sep 17, 2024Buy(P)55K$1.36$75K3.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001373604-24-000094) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML